Life Sciences Times

Heartseed Doses First Patient in Trial of Catheter-Delivered iPSC-Derived Cardiomyocyte Spheroids

Cepheid Donates Hemorrhagic Fever Tests to Support Ebola Bundibugyo Outbreak Response in Africa

Johnson & Johnson Expands U.S. Availability of TECNIS PureSee IOL for Cataract Patients

N-Zyme Biomedical Begins Phase 2 Trial of Pepsin Inhibitor for Reflux Disease

SonoThera Raises $125 Million to Advance Nonviral Genetic Medicine Programs

ValGenesis Hosts ValConnect Innovation Day Events in Lisbon and North Carolina

GENESIS Pharma Expands Alnylam Partnership to Nordic Region

Chiesi Completes Acquisition of KalVista Pharmaceuticals

Vertex Reports CASGEVY Data in Children Ages 5 to 11, Announces Additional Regulatory Submissions

Takeda Says Zasocitinib Outperformed Deucravacitinib in Phase 3 Psoriasis Study